B
Barry R. Davis
Researcher at University of Texas at Austin
Publications - 351
Citations - 50989
Barry R. Davis is an academic researcher from University of Texas at Austin. The author has contributed to research in topics: Chlorthalidone & Amlodipine. The author has an hindex of 78, co-authored 342 publications receiving 47899 citations. Previous affiliations of Barry R. Davis include Tulane University & Cardiovascular Institute of the South.
Papers
More filters
Journal ArticleDOI
Decision rules for predicting future lipid values in screening for a cholesterol reduction clinical trial
TL;DR: A procedure is proposed that predicts the value of an average based on n measurements serially obtained on a patient during the screening phase when only m < n measurements are available, which is applied to population screening for lipid levels above a treatment threshold.
Book ChapterDOI
Data Monitoring in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: Early Termination of the Doxazosin Treatment Arm
Barry R. Davis,Jeffrey A. Cutler +1 more
TL;DR: The doxazosin arm of the ALLHAT trial was terminated earlier than planned due to the low likelihood of finding a significant difference in the primary outcome by the study’s scheduled end and a significant 25% increase in cardiovascular events for doxAZosin compared with chlorthalidone.
Journal ArticleDOI
Association of Sustained Blood Pressure Control with Lower Risk for High-Cost Multimorbidities Among Medicare Beneficiaries in ALLHAT.
C. Barrett Bowling,C. Barrett Bowling,Richard Sloane,Carl F. Pieper,Alison Luciano,Barry R. Davis,Lara M. Simpson,Paula T. Einhorn,Suzanne Oparil,Paul Muntner +9 more
TL;DR: In this article, the association between sustained systolic BP (SBP) control and incident multimorbidity cluster dyads and triads was investigated in the ALLHAT trial linked to Medicare claims.
Journal ArticleDOI
Estimation of protein intake: comparison of dietary assessment and urinary excretion.
Sylvia Wassertheil-Smoller,Herbert G. Langford,Y. Yamori,M. D. Blaufox,Albert Oberman,Barry R. Davis,Y. Nara,Judy Wylie-Rosett,Neal Zimbaldi +8 more
TL;DR: Measurement of urinary protein excretion products may be a useful way to estimate dietary protein intake, and correlations between urinary amino acid excretion and dietary history of protein intake are reported.